Histogen Inc.

Histogen Inc. (https://histogen.com/) is a clinical-stage therapeutics company. The Company is focused on developing restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. It has a portfolio of product candidates derived from one core technology process that utilizes proteins and growth factors produced by hypoxia-induced multipotent cells, without using embryonic stem cells or animal components. The Company's product pipelines include CCM Cosmetics, HST 003, HST 004, and Emricasan. HST 003 is a human extracellular matrix (hECM), a naturally secreted material, which is used for treatment of joint cartilage repair. HST 004 is a cell conditioned medium (CCM) solution, which is used for treatment of spinal disc repair. Emricasan is an orally active pan-caspase inhibitor being jointly developed with its partner Amerimmune for the treatment of COVID-19.

• Histogen Inc.

• Histogen Inc.